Reversible cerebral vasoconstriction syndrome triggered by ondansetron

Acta Neurol Belg. 2021 Aug;121(4):1061-1063. doi: 10.1007/s13760-021-01678-2. Epub 2021 Apr 27.

Authors

Laetitia Della Faille^#¹, Evelien Claesen^#², Sarah Cappelle², Robin Lemmens³

Affiliations

¹ Department of Neurology, University Hospitals Leuven, Leuven, Belgium. laetitia.dellafaille@uzleuven.be.
² Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
³ Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

^# Contributed equally.

PMID: 33905107
DOI: 10.1007/s13760-021-01678-2

No abstract available

Keywords: Arteriopathy; Magnetic resonance imaging; Ondansetron; Reversible cerebral vasoconstriction syndrome.

Publication types

Case Reports

MeSH terms

Antiemetics / adverse effects*
Female
Humans
Ondansetron / adverse effects*
Vasoconstriction / drug effects*
Vasoconstriction / physiology
Vasospasm, Intracranial / chemically induced*
Vasospasm, Intracranial / diagnostic imaging*
Young Adult

Substances

Antiemetics
Ondansetron